Innovating Works

DECIPHEX LIMITED

Desconocido
VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado
BIGPICTURE: Central Repository for Digital Pathology DECIPHEX LIMITED participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to crea...
2020-11-26 - 2027-01-31 | Financiado
PATH-TOX: Artificial Intelligence to transform Drug and Chemical safety testing DECIPHEX LIMITED participó en un H2020: H2020-EIC-FTI-2018-2020 Drug discovery is a time consuming, expensive and risky process. Each drug to market must undergo safety/ toxicity testing in animals which...
2018-10-03 - 2020-10-31 | Financiado
PATHOLYTIX-GI: PATHOLYTIX Using Artificial Intelligence to Transform Clinical Diagnostic Pathology DECIPHEX LIMITED tramitó un H2020: H2020-SMEInst-2016-2017 Routine diagnosis on biopsies and tissues is performed by expert pathologists. However, the pathology sector faces a major crises, due to so...
2017-11-30 - 2018-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.